ICAM-1 促进慢性血栓栓塞性肺动脉高压异常内皮细胞表型
研究比较 172 例 CTEPH 患者肺动脉内膜剥脱标本与 97 例无转移低分期肺癌肺叶切除对照的肺动脉标本,发现 ICAM-1 在 CTEPH 内皮细胞中过表达,促进异常增殖与抗凋亡表型;药理学抑制 ICAM-1 可消除上述异常,机制涉及 SRC、p38、ERK1/2 磷酸化及 survivin 过表达。
要点
- CTEPH 内皮细胞 ICAM-1 过表达,促进异常增殖和抗凋亡。
- 抑制 ICAM-1 合成或活性可逆转内皮细胞异常表型。
- ICAM-1 E469K KE 杂合基因型在 CTEPH 中更常见,但与疾病严重程度无关。
核心结论
- ICAM-1 参与维持 CTEPH 中异常的内皮细胞表型。
研究设计与样本
- 研究 172 例 CTEPH 患者肺动脉内膜剥脱标本与 97 例无转移低分期肺癌肺叶切除对照的肺动脉标本。
主要发现
- ICAM-1 在 CTEPH 内皮细胞中过表达,内皮细胞生长和抗凋亡显著高于对照(p < 0.001)。
- 药理学抑制 ICAM-1 合成或活性可消除内皮细胞生长和抗凋亡异常。
- ICAM-1 过表达通过 SRC、p38 和 ERK1/2 磷酸化及 survivin 过表达促进异常表型。
- ICAM-1 E469K KE 杂合基因型在 CTEPH 中显著更常见,但与 CTEPH 患者疾病严重程度无关。
临床怎么用
- ICAM-1 及其下游 SRC/p38/ERK1/2-survivin 通路可作为 CTEPH 内皮细胞异常表型的潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary endothelial cells play a key role in the pathogenesis of Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Increased synthesis and/or the release of intercellular adhesion molecule-1 (ICAM-1) by pulmonary endothelial cells of patients with CTEPH has been recently reported, suggesting a potential role for ICAM-1 in CTEPH. METHODS: We studied pulmonary endarterectomy specimens from 172 patients with CTEPH and pulmonary artery specimens from 97 controls undergoing lobectomy for low-stage cancer without metastasis. RESULTS: ICAM-1 was overexpressed in vitro in isolated and cultured endothelial cells from endarterectomy specimens. Endothelial cell growth and apoptosis resistance were significantly higher in CTEPH specimens than in the controls (p < 0.001). Both abnormalities were abolished by pharmacological inhibition of ICAM-1 synthesis or activity. The overexpression of ICAM-1 contributed to the acquisition and maintenance of abnormal EC growth and apoptosis resistance via the phosphorylation of SRC, p38 and ERK1/2 and the overproduction of survivin. Regarding the ICAM-1 E469K polymorphism, the KE heterozygote genotype was significantly more frequent in CTEPH than in the controls, but it was not associated with disease severity among patients with CTEPH. CONCLUSIONS: ICAM-1 contributes to maintaining the abnormal endothelial cell phenotype in CTEPH.
引用
- Arthur Ataam J, Mercier O, Lamrani L, et al. ICAM-1 promotes the abnormal endothelial cell phenotype in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2019. PMID: 31324443. doi:10.1016/j.healun.2019.06.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。